This month, the Court of Justice of the European Union (CJEU) addressed a case of particular interest for pharmaceutical companies that are in the process of developing a new product. Regulatory and commercial considerations...more
7/19/2019
/ Advertising ,
Appeals ,
Clinical Trials ,
Court of Justice of the European Union (CJEU) ,
General Court of the European Union (GCEU) ,
Intellectual Property Protection ,
Marketing Perspectives ,
Non-Use of Trademarks ,
Pharmaceutical Industry ,
Regulatory Standards ,
Revocation ,
Trademarks
In the aftermath of this year investigation against business operators not complying with the requirement of Italian law on label notification (see here), the Italian Competition Authority ("Authority") - in charge of...more
By decision No. 10892 published on 7 May 2018, the Italian Supreme Court ruled on an appeal brought by the Ministry of Health against a decision of the appellate Court of Padua in a case concerning the administrative...more
The Court of Milan held in a Judgment recently handed down in the proceedings brought by Bayer S.p.a. against the generic manufacturer DOC Generici S.r.l. that online publication of over-the-counter (OTC) medicinal products...more